纽约州寨卡病毒血清学检测策略的建立
纽约州Wadsworth中心对超过10000份标本采用ELISA检测寨卡病毒IgM抗体、多价微球免疫分析检测黄病毒广反应性抗体及蚀斑减少中和试验进一步检测。42%患者有黄病毒感染的血清学证据,7%具有寨卡和/或登革病毒IgM抗体;PRNT分析826份IgM阳性标本显示7%仅中和寨卡、9%仅中和登革、85%两者均中和,黄病毒间广泛抗体交叉反应降低PRNT价值,据此实施新检测算法。
要点
- 寨卡IgM抗体通常在症状出现后3至4天内产生,仅1例持续时间超过100天。
- PRNT分析826份IgM阳性标本中,85%对寨卡和登革病毒均呈中和反应。
- 黄病毒广泛交叉反应显著降低PRNT分析价值,尤其传统配对血清算法。
核心结论
- 黄病毒间广泛抗体交叉反应显著降低PRNT分析价值,尤其使用传统配对血清算法时。
- PRNT阴性结果对 reassuring 医生和患者极有价值,MIA可识别无IgM但具寨卡特异性中和抗体的患者。
研究设计与样本
- 在Wadsworth中心对超过10000份标本进行寨卡病毒血清学检测,采用IgM ELISA、多价微球免疫分析(MIA)和蚀斑减少中和试验(PRNT)组合。
- PRNT分析针对826份IgM阳性标本进行。
主要发现
- 42%患者显示黄病毒感染血清学证据(主要为既往登革病毒感染),7%具有寨卡和/或登革病毒IgM抗体。
- 寨卡IgM抗体通常在3至4天内出现,仅1例持续时间超过100天。
- PRNT分析826份IgM阳性标本:7%仅中和寨卡病毒,9%仅中和登革病毒,85%两者均中和。
关键数值与推荐
- 寨卡IgM抗体通常在症状报告后3至4天内产生,仅1例持续时间超过100天。
- PRNT分析826份IgM阳性标本中,7%阳性中和寨卡病毒 alone,9%登革病毒 alone,85%两者均中和。
临床怎么用
- 实施新算法:IgM抗体捕获(MAC)-ELISA检测近期感染,黄病毒MIA识别不再产生IgM的患者,单稀释PRNT用于寨卡排除和偶尔鉴别寨卡与登革病毒。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The recent outbreak of Zika virus (ZIKV) in the Americas has challenged diagnostic laboratory testing strategies. At the Wadsworth Center, ZIKV serological testing was performed for over 10,000 specimens, using a combination of an enzyme-linked immunosorbent assay (ELISA) for IgM antibodies (Abs) to ZIKV, a polyvalent microsphere immunoassay (MIA) to detect Abs broadly reactive with flaviviruses, and a plaque reduction neutralization test (PRNT) for further testing. Overall, 42% of patients showed serological evidence of flavivirus infection (primarily past dengue virus [DENV] infection), while 7% possessed IgM Abs to ZIKV and/or DENV. ZIKV IgM Abs typically arose within 3 to 4 days, with only one instance of duration beyond 100 days after reported symptoms. PRNT analysis of 826 IgM-positive specimens showed 7% positive neutralization to ZIKV alone, 9% to DENV alone, and 85% to both ZIKV and DENV. Thus, the extensive Ab cross-reactivity among flaviviruses significantly reduced the value of performing PRNT analysis, especially when a traditional paired serum algorithm with viral neutralization titering was used. Nevertheless, the finding of a negative ZIKV result by PRNT was invaluable for reassuring both physicians and patients. The MIA detected both IgM and IgG, which enabled us to identify patients who presented without IgM anti-ZIKV Abs but still had ZIKV-specific neutralizing Abs. On the basis of these results, a new algorithm, which included an IgM Ab capture (MAC)-ELISA to detect recent infection, a flavivirus MIA to identify patients no longer producing IgM, and a single-dilution PRNT for ZIKV exclusion and occasional discrimination of ZIKV and DENV, was implemented.
引用
- Lee WT, Wong SJ, Kulas KE, et al. Development of Zika Virus Serological Testing Strategies in New York State. J Clin Microbiol. 2018. PMID: 29263203. doi:10.1128/JCM.01591-17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。